CRT, including volume-based brachytherapy, followed by pembrolizumab demonstrated a statistically significant and clinically meaningful improvement in progression-free survival, along with a favorable trend in overall survival, in patients with locally advanced high-risk cervical cancer.
← all excerpts
Novel Treatment Concepts for Cervical Cancer-Moving Towards Personalized Therapy.
1
—
—